Cytochroma

Cytochroma is a biotechnology company focused on transforming drug discovery and development through the use of genetically diverse, stem cell-derived mini-organs. The company utilizes induced pluripotent stem cells (iPSCs) to manufacture animal-free, physiologically relevant mini-livers and mini-hearts. These models are integrated with their proprietary 'Wet AI' platform, which combines large-scale laboratory experiments with machine learning to generate phenotypic data, enabling pharmaceutical companies to predict drug safety and efficacy across diverse global populations early in the preclinical phase. Cytochroma is recognized for its commitment to inclusivity and ethical testing, maintaining one of the world's largest commercially available libraries of diverse iPSC-derived cells (including donors of Asian, African, and European backgrounds). This allows for the detection of gender- and ethnicity-specific drug responses, aligning with recent regulatory shifts such as the FDA Modernization Act, which encourages alternatives to animal testing. The company operates primarily as a technology and service provider for drug discovery and validation.